Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2014

Open Access 01-12-2014 | Research

The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States

Authors: Michael L Ganz, Neil Wintfeld, Qian Li, Veronica Alas, Jakob Langer, Mette Hammer

Published in: Diabetology & Metabolic Syndrome | Issue 1/2014

Login to get access

Abstract

Objectives

Obesity is a known risk factor for type 2 diabetes (T2D). We conducted a case–control study to assess the association between body mass index (BMI) and the risk of being diagnosed with T2D in the United States.

Methods

We selected adults (≥ 18 years old) who were diagnosed with T2D (defined by ICD-9-CM diagnosis codes or use of anti-diabetic medications) between January 2004 and October 2011 (“cases”) from an electronic health records database provided by an integrated health system in the Middle Atlantic region. Twice as many individuals enrolled in the health system without a T2D diagnosis during the study period (“controls”) were selected based on age, sex, history of cardiac comorbidities or hyperinflammatory state (defined by C-reactive protein and erythrocyte sedimentation rate), and use of psychiatric or beta blocker medications. BMI was measured during one year prior to the first observed T2D diagnosis (for cases) or a randomly assigned date (for controls); individuals with no BMI measure or BMI < 18.5 kg/m2 were excluded. We assessed the impact of increased BMI (overweight: 25–29.9 kg/m2; Obesity Class I: 30–34.9 kg/m2; Obesity Class II: 35–39.9 kg/m2; Obesity Class III: ≥40 kg/m2), relative to normal BMI (18.5–24.9 kg/m2), on a T2D diagnosis using odds ratios (OR) and relative risks (RR) estimated from multiple logistic regression results.

Results

We included 12,179 cases (mean age: 55, 43% male) and 25,177 controls (mean age: 56, 45% male). We found a positive association between BMI and the risk of a T2D diagnosis. The strength of this association increased with BMI category (RR [95% confidence interval]: overweight, 1.5 [1.4–1.6]; Obesity Class I, 2.5 [2.3–2.6]; Obesity Class II, 3.6 [3.4–3.8]; Obesity Class III, 5.1 [4.7–5.5]).

Conclusions

BMI is strongly and independently associated with the risk of being diagnosed with T2D. The incremental association of BMI category on the risk of T2D is stronger for people with a higher BMI relative to people with a lower BMI.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998, 317 (7160): 703-713. 10.1136/bmj.317.7160.703. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998, 317 (7160): 703-713. 10.1136/bmj.317.7160.703.
2.
go back to reference Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002, 287 (19): 2570-2581. 10.1001/jama.287.19.2570.CrossRefPubMed Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002, 287 (19): 2570-2581. 10.1001/jama.287.19.2570.CrossRefPubMed
3.
go back to reference Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B: Deaths: final data for 2006. Natl Vital Stat Rep. 2009, 57 (14): 1-134.PubMed Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B: Deaths: final data for 2006. Natl Vital Stat Rep. 2009, 57 (14): 1-134.PubMed
4.
go back to reference Riddle MC: Glycemic control and cardiovascular mortality. Curr Opin Endocrinol Diabetes Obes. 2011, 18 (2): 104-109. 10.1097/MED.0b013e3283446b7e.CrossRefPubMed Riddle MC: Glycemic control and cardiovascular mortality. Curr Opin Endocrinol Diabetes Obes. 2011, 18 (2): 104-109. 10.1097/MED.0b013e3283446b7e.CrossRefPubMed
5.
go back to reference Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013, 36 (4): 1033-1046. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013, 36 (4): 1033-1046.
6.
go back to reference National Institute of Diabetes and Digestive and Kidney Diseases: National Diabetes Statistics, 2007 Fact Sheet. 2008, Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases: National Diabetes Statistics, 2007 Fact Sheet. 2008, Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health
7.
go back to reference Centers for Disease Control and Prevention: National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. 2011, Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention Centers for Disease Control and Prevention: National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. 2011, Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention
8.
9.
go back to reference Garber AJ: Obesity and type 2 diabetes: which patients are at risk?. Diabetes Obes Metab. 2012, 14 (5): 399-408. 10.1111/j.1463-1326.2011.01536.x.CrossRefPubMed Garber AJ: Obesity and type 2 diabetes: which patients are at risk?. Diabetes Obes Metab. 2012, 14 (5): 399-408. 10.1111/j.1463-1326.2011.01536.x.CrossRefPubMed
10.
go back to reference Flegal KM, Carroll MD, Kit BK, Ogden CL: Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012, 307 (5): 491-497. 10.1001/jama.2012.39.CrossRefPubMed Flegal KM, Carroll MD, Kit BK, Ogden CL: Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012, 307 (5): 491-497. 10.1001/jama.2012.39.CrossRefPubMed
11.
go back to reference Cawley J, Meyerhoefer C: The medical care costs of obesity: an instrumental variables approach. J Health Econ. 2012, 31 (1): 219-230. 10.1016/j.jhealeco.2011.10.003.CrossRefPubMed Cawley J, Meyerhoefer C: The medical care costs of obesity: an instrumental variables approach. J Health Econ. 2012, 31 (1): 219-230. 10.1016/j.jhealeco.2011.10.003.CrossRefPubMed
12.
go back to reference Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK: Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring). 2008, 16 (10): 2323-2330. 10.1038/oby.2008.351.CrossRef Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK: Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring). 2008, 16 (10): 2323-2330. 10.1038/oby.2008.351.CrossRef
13.
go back to reference Kodama S, Horikawa C, Fujihara K, Heianza Y, Hirasawa R, Yachi Y, Sugawara A, Tanaka S, Shimano H, Iida KT, Saito K, Sone H: Comparisons of the strength of associations with future type 2 diabetes risk among anthropometric obesity indicators, including waist-to-height ratio: a meta-analysis. Am J Epidemiol. 2012, 176 (11): 959-969. 10.1093/aje/kws172.CrossRefPubMed Kodama S, Horikawa C, Fujihara K, Heianza Y, Hirasawa R, Yachi Y, Sugawara A, Tanaka S, Shimano H, Iida KT, Saito K, Sone H: Comparisons of the strength of associations with future type 2 diabetes risk among anthropometric obesity indicators, including waist-to-height ratio: a meta-analysis. Am J Epidemiol. 2012, 176 (11): 959-969. 10.1093/aje/kws172.CrossRefPubMed
14.
go back to reference Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, Speizer FE, Manson JE: Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women, The Nurses' Health Study. Am J Epidemiol. 1997, 145 (7): 614-619. 10.1093/oxfordjournals.aje.a009158.CrossRefPubMed Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, Speizer FE, Manson JE: Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women, The Nurses' Health Study. Am J Epidemiol. 1997, 145 (7): 614-619. 10.1093/oxfordjournals.aje.a009158.CrossRefPubMed
15.
go back to reference Shai I, Jiang R, Manson JE, Stampfer MJ, Willett WC, Colditz GA, Hu FB: Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care. 2006, 29 (7): 1585-1590. 10.2337/dc06-0057.CrossRefPubMed Shai I, Jiang R, Manson JE, Stampfer MJ, Willett WC, Colditz GA, Hu FB: Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care. 2006, 29 (7): 1585-1590. 10.2337/dc06-0057.CrossRefPubMed
16.
go back to reference Abdullah A, Stoelwinder J, Shortreed S, Wolfe R, Stevenson C, Walls H, de Courten M, Peeters A: The duration of obesity and the risk of type 2 diabetes. Public Health Nutr. 2011, 14 (1): 119-126. 10.1017/S1368980010001813.CrossRefPubMed Abdullah A, Stoelwinder J, Shortreed S, Wolfe R, Stevenson C, Walls H, de Courten M, Peeters A: The duration of obesity and the risk of type 2 diabetes. Public Health Nutr. 2011, 14 (1): 119-126. 10.1017/S1368980010001813.CrossRefPubMed
17.
go back to reference Wang H, Shara NM, Calhoun D, Umans JG, Lee ET, Howard BV: Incidence rates and predictors of diabetes in those with prediabetes: the Strong Heart Study. Diabetes Metab Res Rev. 2010, 26 (5): 378-385. 10.1002/dmrr.1089.PubMedCentralCrossRefPubMed Wang H, Shara NM, Calhoun D, Umans JG, Lee ET, Howard BV: Incidence rates and predictors of diabetes in those with prediabetes: the Strong Heart Study. Diabetes Metab Res Rev. 2010, 26 (5): 378-385. 10.1002/dmrr.1089.PubMedCentralCrossRefPubMed
18.
go back to reference Zindah M, Belbeisi A, Walke H, Mokdad AH: Obesity and diabetes in Jordan: findings from the behavioral risk factor surveillance system, 2004. Prev Chronic Dis. 2008, 5 (1): A17-PubMedCentralPubMed Zindah M, Belbeisi A, Walke H, Mokdad AH: Obesity and diabetes in Jordan: findings from the behavioral risk factor surveillance system, 2004. Prev Chronic Dis. 2008, 5 (1): A17-PubMedCentralPubMed
19.
go back to reference Krishnan SRL, Djousse L, Cupples LA, Palmer JR: Overall and central obesity and risk of type 2 diabetes in U.S. black women. Obesity (Silver Spring). 2007, 15 (7): 1860-1866. 10.1038/oby.2007.220.CrossRef Krishnan SRL, Djousse L, Cupples LA, Palmer JR: Overall and central obesity and risk of type 2 diabetes in U.S. black women. Obesity (Silver Spring). 2007, 15 (7): 1860-1866. 10.1038/oby.2007.220.CrossRef
20.
go back to reference Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003, 289 (1): 76-79.CrossRefPubMed Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003, 289 (1): 76-79.CrossRefPubMed
21.
go back to reference Velasco Mondragon HE, Charlton RW, Peart T, Burguete-Garcia AI, Hernandez-Avila M, Hsueh WC: Diabetes risk assessment in Mexicans and Mexican Americans: effects of parental history of diabetes are modified by adiposity level. Diabetes Care. 2010, 33 (10): 2260-2265. 10.2337/dc10-0992.PubMedCentralCrossRefPubMed Velasco Mondragon HE, Charlton RW, Peart T, Burguete-Garcia AI, Hernandez-Avila M, Hsueh WC: Diabetes risk assessment in Mexicans and Mexican Americans: effects of parental history of diabetes are modified by adiposity level. Diabetes Care. 2010, 33 (10): 2260-2265. 10.2337/dc10-0992.PubMedCentralCrossRefPubMed
22.
go back to reference Asche C, Nelson R, McAdam-Marx C, Jhaveri M, Ye X: Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA. Osteoporos Int. 2010, 21 (8): 1427-1436. 10.1007/s00198-009-1079-7.PubMedCentralCrossRefPubMed Asche C, Nelson R, McAdam-Marx C, Jhaveri M, Ye X: Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA. Osteoporos Int. 2010, 21 (8): 1427-1436. 10.1007/s00198-009-1079-7.PubMedCentralCrossRefPubMed
23.
go back to reference Herout PM, Harshaw Q, Phatak H, Saka G, McNeill A, Wu D, Sazonov V, DeSagun R, Shirani J: Impact of worsening renal function during hospital admission on resource utilization in patients with heart failure. Am J Cardiol. 2010, 106 (8): 1139-1145. 10.1016/j.amjcard.2010.06.026.CrossRefPubMed Herout PM, Harshaw Q, Phatak H, Saka G, McNeill A, Wu D, Sazonov V, DeSagun R, Shirani J: Impact of worsening renal function during hospital admission on resource utilization in patients with heart failure. Am J Cardiol. 2010, 106 (8): 1139-1145. 10.1016/j.amjcard.2010.06.026.CrossRefPubMed
24.
go back to reference Nordstrom BL, Kachroo S, Fraeman KH, Nutescu EA, Schein JR, Fisher A, Bookhart BK: Warfarin prophylaxis in patients after total knee or hip arthroplasty–international normalized ratio patterns and venous thromboembolism. Curr Med Res Opin. 2011, 27 (10): 1973-1985. 10.1185/03007995.2011.614938.CrossRefPubMed Nordstrom BL, Kachroo S, Fraeman KH, Nutescu EA, Schein JR, Fisher A, Bookhart BK: Warfarin prophylaxis in patients after total knee or hip arthroplasty–international normalized ratio patterns and venous thromboembolism. Curr Med Res Opin. 2011, 27 (10): 1973-1985. 10.1185/03007995.2011.614938.CrossRefPubMed
25.
go back to reference Stecker MM: The EEG as an independent indicator of mortality and healthcare utilization. Clin Neurophysiol. 2009, 120 (10): 1777-1781. 10.1016/j.clinph.2009.07.041.CrossRefPubMed Stecker MM: The EEG as an independent indicator of mortality and healthcare utilization. Clin Neurophysiol. 2009, 120 (10): 1777-1781. 10.1016/j.clinph.2009.07.041.CrossRefPubMed
26.
go back to reference Wu EQ, Zhou S, Yu A, Lu M, Sharma H, Gill J, Graf T: Outcomes associated with insulin therapy disruption after hospital discharge among patients with type 2 diabetes mellitus who had used insulin before and during hospitalization. Endocr Pract. 2012, 18 (5): 651-659. 10.4158/EP11314.OR.CrossRefPubMed Wu EQ, Zhou S, Yu A, Lu M, Sharma H, Gill J, Graf T: Outcomes associated with insulin therapy disruption after hospital discharge among patients with type 2 diabetes mellitus who had used insulin before and during hospitalization. Endocr Pract. 2012, 18 (5): 651-659. 10.4158/EP11314.OR.CrossRefPubMed
28.
go back to reference Kleinman LC, Norton EC: What's the Risk? A simple approach for estimating adjusted risk measures from nonlinear models including logistic regression. Health Serv Res. 2009, 44 (1): 288-302. 10.1111/j.1475-6773.2008.00900.x.PubMedCentralCrossRefPubMed Kleinman LC, Norton EC: What's the Risk? A simple approach for estimating adjusted risk measures from nonlinear models including logistic regression. Health Serv Res. 2009, 44 (1): 288-302. 10.1111/j.1475-6773.2008.00900.x.PubMedCentralCrossRefPubMed
29.
go back to reference Efron B: TR: An Introduction to the Bootstrap. 1993, New York: Chapman and Hall,CrossRef Efron B: TR: An Introduction to the Bootstrap. 1993, New York: Chapman and Hall,CrossRef
30.
go back to reference Rothman KJ: Epidemiology: An Introduction. 2002, Oxford University press: New York Rothman KJ: Epidemiology: An Introduction. 2002, Oxford University press: New York
31.
go back to reference Burkhauser RV, Cawley J: Beyond BMI: the value of more accurate measures of fatness and obesity in social science research. J Health Econ. 2008, 27 (2): 519-529. 10.1016/j.jhealeco.2007.05.005.CrossRefPubMed Burkhauser RV, Cawley J: Beyond BMI: the value of more accurate measures of fatness and obesity in social science research. J Health Econ. 2008, 27 (2): 519-529. 10.1016/j.jhealeco.2007.05.005.CrossRefPubMed
32.
go back to reference Plankey MW, Stevens J, Flegal KM, Rust PF: Prediction equations do not eliminate systematic error in self-reported body mass index. Obes Res. 1997, 5 (4): 308-314. 10.1002/j.1550-8528.1997.tb00556.x.CrossRefPubMed Plankey MW, Stevens J, Flegal KM, Rust PF: Prediction equations do not eliminate systematic error in self-reported body mass index. Obes Res. 1997, 5 (4): 308-314. 10.1002/j.1550-8528.1997.tb00556.x.CrossRefPubMed
33.
go back to reference Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002, 346 (6): 393-403.CrossRefPubMed Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002, 346 (6): 393-403.CrossRefPubMed
34.
go back to reference Perreault L, Kahn SE, Christophi CA, Knowler WC, Hamman RF: Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care. 2009, 32 (9): 1583-1588. 10.2337/dc09-0523.PubMedCentralCrossRefPubMed Perreault L, Kahn SE, Christophi CA, Knowler WC, Hamman RF: Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care. 2009, 32 (9): 1583-1588. 10.2337/dc09-0523.PubMedCentralCrossRefPubMed
35.
go back to reference Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM: 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009, 374 (9702): 1677-1686.CrossRefPubMed Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM: 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009, 374 (9702): 1677-1686.CrossRefPubMed
36.
go back to reference Pawaskar M, Li Q, Hoogwerf BJ, Reynolds MW, Faries D, Engelman W, Bruhn D, Bergenstal RM: Metabolic outcomes of matched patient populations initiating exenatide BID vs. insulin glargine in an ambulatory care setting. Diabetes Obes Metab. 2012, 14 (7): 626-633. 10.1111/j.1463-1326.2012.01581.x.CrossRefPubMed Pawaskar M, Li Q, Hoogwerf BJ, Reynolds MW, Faries D, Engelman W, Bruhn D, Bergenstal RM: Metabolic outcomes of matched patient populations initiating exenatide BID vs. insulin glargine in an ambulatory care setting. Diabetes Obes Metab. 2012, 14 (7): 626-633. 10.1111/j.1463-1326.2012.01581.x.CrossRefPubMed
37.
go back to reference Wu N, Aagren M, Boulanger L, Friedman M, Wilkey K: Assessing achievement and maintenance of glycemic control by patients initiating basal insulin. Curr Med Res Opin. 2012, 28 (10): 1647-1656. 10.1185/03007995.2012.722989.CrossRefPubMed Wu N, Aagren M, Boulanger L, Friedman M, Wilkey K: Assessing achievement and maintenance of glycemic control by patients initiating basal insulin. Curr Med Res Opin. 2012, 28 (10): 1647-1656. 10.1185/03007995.2012.722989.CrossRefPubMed
Metadata
Title
The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States
Authors
Michael L Ganz
Neil Wintfeld
Qian Li
Veronica Alas
Jakob Langer
Mette Hammer
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2014
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-6-50

Other articles of this Issue 1/2014

Diabetology & Metabolic Syndrome 1/2014 Go to the issue